Fort Worth, Texas - September 02, 2026 - PRESSADVANTAGE - Pediatric Eye Specialists has released a new educational ...
TORONTO ― The selective serotonin reuptake inhibitor (SSRI) fluoxetine (multiple brands), a first-line treatment for adults with body dysmorphic disorder (BDD), may also help in pediatric BDD, results ...
Assessing body composition in children and adolescents is fundamental for understanding growth, nutritional status and disease risk. Unlike simple anthropometry, which relies on weight and height ...
Methylation profiling of hypomethylating agent response and treatment failure in pediatric and young adult MDS/AML. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract ...
FORUM is a randomized, controlled, open-label, international, multicenter, phase III, noninferiority study. Patients ≤ 18 years at diagnosis, 4-21 years at HSCT, in complete remission pre-HSCT, and ...
Initial pediatric subject shows sustained benefit with QRX003; second patient approved for full-body treatment in ongoing Netherton syndrome study ASHBURN, VA, April 2, 2025 (EZ Newswire) -- Quoin ...